AgeCurve

Cambridge, United Kingdom

AgeCurve is a biotechnology company that uses evolutionary cell lineage trees to unlock the predictive power somatic mutations.

$313K raised

Feb 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AgeCurve raised?

AgeCurve has raised $313K in total funding. The most recent round was Seed. The last funding was announced in February 2024.

Who are AgeCurve's investors?

AgeCurve's investors include Longevitytech.fund.

Where is AgeCurve headquartered?

AgeCurve is headquartered in Cambridge, United Kingdom.

What does AgeCurve do?

AgeCurve is a biotechnology company that uses evolutionary cell lineage trees to unlock the predictive power somatic mutations.

What stage is AgeCurve at?

AgeCurve is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 5, 2024.

MLA

"AgeCurve — Funding & Investors." VCBacked, February 5, 2024, https://www.vcbacked.co/company/agecurve. Accessed July 3, 2026.

APA

VCBacked. (2024). AgeCurve — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/agecurve

Wikipedia (cite web)

{{cite web |title=AgeCurve — Funding & Investors |url=https://www.vcbacked.co/company/agecurve |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 5, 2024.